Expression of ALDH1 in breast invasive ductal carcinoma: An independent predictor of early tumor relapse

Cancer Cell International

Volumn 13, Issue 1, 2013, Pages

  Zhong, Ying ^a   Lin, Yan ^a   Shen, Songjie ^a   Zhou, Yidong ^a   Mao, Feng ^a   Guan, Jinghong ^a   Sun, Qiang ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Aldehyde dehydrogenase 1; Breast; Invasive ductal carcinoma; Prognosis

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE 1 A1; ALDEHYDE DEHYDROGENASE ISOENZYME 1; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR; KI 67 ANTIGEN; MESSENGER RNA; NOTCH1 RECEPTOR; PROGESTERONE RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BREAST CARCINOMA; CANCER PROGNOSIS; CANCER RECURRENCE; CONTROLLED STUDY; GENETIC CORRELATION; HUMAN; HUMAN TISSUE; METASTASIS; PHENOTYPE; PROTEIN EXPRESSION;

EID: 84878894469     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/1475-2867-13-60     Document Type: Article

References (35)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010, 60:277-300. 10.3322/caac.20073, 20610543.
2. Ozbay T, Nahta R. Delphinidin inhibits HER2 and Erk1/2 signaling and suppresses growth of HER2-overexpressing and triple negative breast cancer cell lines. Breast Cancer 2011, 5:143-154. 3140266, 21792311.
3. Voduc KD, Cheang MC, Tyldesley S, Gelmon K, Nielsen TO, Kennecke H. Breast cancer subtypes and the risk of local and regional relapse. J Clin Oncol 2010, 28:1684-1691. 10.1200/JCO.2009.24.9284, 20194857.
4. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001, 414:105-111. 10.1038/35102167, 11689955.
5. Kleer CG, Zhang Y, Pan Q, Gallagher G, Wu M, Wu ZF, Merajver SD. WISP3 and RhoC guanosine triphosphatase cooperate in the development of inflammatory breast cancer. Breast Cancer Res 2004, 6:R110-R115. 10.1186/bcr755, 15602803.
6. Van den Eynden GG, Van Laere SJ, Van der Auwera I, Merajver SD, Van Marck EA, Van Dam P, Vermeulen PB, Dirix LY, Van Golen KL. Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer. Breast Cancer Res Treat 2006, 95:219-228. 10.1007/s10549-005-9002-1, 16244790.
7. Van Laere SJ, Van der Auwera I, Van den Eynden GG, Elst HJ, Weyler J, Harris AL, Van Dam P, Van Marck EA, Vermeulen PB, Dirix LY. Nuclear factor-κB signature of inflammatory breast cancer by cDNA microarray validated by quantitative real-time reverse transcription-PCR, immunohistochemistry, and nuclear factor-κB DNA-binding. Clin Cancer Res 2006, 12:3249-3256. 10.1158/1078-0432.CCR-05-2800, 16740744.
8. Wu M, Wu ZF, Kumar-Sinha C, Chinnaiyan A, Merajver SD. RhoC induces differential expression of genes involved in invasion and metastasis in MCF10A breast cells. Breast Cancer Res Treat 2004, 84:3-12. 10.1023/B:BREA.0000018426.76893.21, 14999149.
9. Nakshatri H, Srour EF, Badve S. Breast cancer stem cells and intrinsic subtypes: controversies rage on. Curr Stem Cell Res Ther 2009, 4:50-60. 10.2174/157488809787169110, 19149630.
10. Zucchi I, Sanzone S, Astigiano S, Pelucchi P, Scotti M, Valsecchi V, Barbieri O, Bertoli G, Albertini A, Reinbold RA, Dulbecco R. The properties of a mammary gland cancer stem cell. Proc Natl Acad Sci USA 2007, 104:10476-10481. 10.1073/pnas.0703071104, 1965538, 17566110.
11. Chute JP, Muramoto GG, Whitesides J, Colvin M, Safi R, Chao NJ, McDonnell DP. Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells. Proc Natl Acad Sci USA 2006, 103:11707-11712. 10.1073/pnas.0603806103, 1544234, 16857736.
12. Povsic TJ, Zavodni KL, Kelly FL, Zhu S, Goldschmidt-Clermont PJ, Dong C, Peterson ED. Circulating progenitor cells can be reliably identified on the basis of aldehyde dehydrogenase activity. J Am Coll Cardiol 2007, 50:2243-2248. 10.1016/j.jacc.2007.08.033, 18061073.
13. Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG, Liu S, Schott A, Hayes D, Birnbaum D, Wicha MS, Dontu G. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007, 1:555-567. 10.1016/j.stem.2007.08.014, 2423808, 18371393.
14. Ma I, Allan AL. The role of human aldehyde dehydrogenase in normal and cancer stem cells. Stem Cell Rev 2011, 7(2):292-306. 10.1007/s12015-010-9208-4, 21103958.
15. Charafe-Jauffret E, Ginestier C, Iovino F, Tarpin C, Diebel M, Esterni B, Houvenaeghel G, Extra JM, Bertucci F, Jacquemier J, Xerri L, Dontu G, Stassi G, Xiao Y, Barsky SH, Birnbaum D, Viens P, Wicha MS. Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer. Clin Cancer Res 2010, 16(1):45-55. 10.1158/1078-0432.CCR-09-1630, 2874875, 20028757.
16. Krause DS. Regulation of hematopoietic stem cell fate. Oncogene 2002, 21:3262-3269. 10.1038/sj.onc.1205316, 12032767.
17. Smith GH, Chepko G. Mammary epithelial stem cells. Microsc Res Tech 2001, 52:190-203. 10.1002/1097-0029(20010115)52:2<190::AID-JEMT1005>3.0.CO;2-O, 11169867.
18. Dontu G, Jackson KW, McNicholas E, Kawamura MJ, Abdallah WM, Wicha MS. Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells. Breast Cancer Res 2004, 6:R605-R615. 10.1186/bcr920, 1064073, 15535842.
19. Gallahan D, Callahan R. The mouse mammary tumor associated gene INT3 is a unique member of the NOTCH gene family (NOTCH4). Oncogene 1997, 14:1883-1890. 10.1038/sj.onc.1201035, 9150355.
20. Callahan R, Egan SE. Notch signaling in mammary development and oncogenesis. J Mammary Gland Biol Neoplasia 2004, 9:145-163.
21. Radtke F, Raj K. The role of notch in tumorigenesis: oncogene or tumour suppressor?. Nature Reviews Cancer 2003, 3:756-767. 10.1038/nrc1186, 14570040.
22. Chunhua S, Zhenguang C, Honghe L, Yihua S, Wangkai L, Lie C, Tao W, Yiyan L, Beilong Z. Different patterns of NF-κB and Notch1 signaling contribute to tumor-induced lymphangiogenesis of esophageal squamous cell carcinoma. J Exp Clin Cancer Res 2011, 30:85-94. 10.1186/1756-9966-30-85, 3215933, 21939555.
23. UICC International Union Against Cancer (UICC), TNM Classification of Malignant Tumours 2002, New York: Wiley-Liss, 6, UICC.
24. Devilee P, Tavassoli FA. World Health Organization: Tumours of the Breast and Female Genital Organs 2003, Oxford [Oxfordshire]: Oxford University Press.
25. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-△△CT method. Methods 2001, 25:402-408. 10.1006/meth.2001.1262, 11846609.
26. Jiang F, Qiu Q, Khanna A, Todd NW, Deepak J, Xing L, Wang H, Liu Z, Su Y, Stass SA, Katz RL. Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer. Mol Cancer Res 2008, 7:330-338.
27. Patrawala L, Calhoun-Davis T, Schneider-Broussard R, Tang DG. Hierarchical organization of prostate cancer cells in xenograft tumors: the CD44+α2β1+ cell population is enriched in tumor-initiating cells. Cancer Res 2007, 67:6796-6805. 10.1158/0008-5472.CAN-07-0490, 17638891.
28. Chen YC, Chen YW, Hsu HS, Tseng LM, Huang PI, Lu KH, Chen DT, Tai LK, Yung MC, Chang SC, Ku HH, Chiou SH, Lo WL. Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer. Biochem Biophys Res Commun 2009, 385:307-313. 10.1016/j.bbrc.2009.05.048, 19450560.
29. Su Y, Qiu Q, Zhang X, Jiang Z, Leng Q, Liu Z, Stass SA, Jiang F. Enriched in tumor-initiating cells and associated with aldehyde dehydrogenase 1 A1-positive cell population is progression of bladder cancer. Cancer Epidemiol Biomarkers Prev 2010, 19:327-337. 10.1158/1055-9965.EPI-09-0865, 3544173, 20142235.
30. Kunju LP, Cookingham C, Toy KA, Chen W, Sabel MS, Kleer CG. EZH2 and ALDH-1 mark breast epithelium at risk for breast cancer development. Mod Pathol 2011, 24(6):786-793. 10.1038/modpathol.2011.8, 3106137, 21399615.
31. Resetkova E, Reis-Filho JS, Jain RK, Mehta R, Thorat MA, Nakshatri H, Badve S. Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment. Breast Cancer Res Treat 2010, 123(1):97-108. 10.1007/s10549-009-0619-3, 19911270.
32. Croker AK, Allan AL. Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDH(hi)CD44 (+) human breast cancer cells. Breast Cancer Res Treat 2012, 133(1):75-87. 10.1007/s10549-011-1692-y, 21818590.
33. Miele L. Notch signaling. Clin Cancer Res 2006, 12(4):1074-1079. 10.1158/1078-0432.CCR-05-2570, 16489059.
34. Rizzo P, Miao H, D'Souza G, Osipo C, Song LL, Yun J, Zhao H, Mascarenhas J, Wyatt D, Antico G, Hao L, Yao K, Rajan P, Hicks C, Siziopikou K, Selvaggi S, Bashir A, Bhandari D, Marchese A, Lendahl U, Qin JZ, Tonetti DA, Albain K, Nickoloff BJ, Miele L. Cross-talk between notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches. Cancer Res 2008, 68(13):5226-5235. 10.1158/0008-5472.CAN-07-5744, 18593923.
35. Stylianou S, Clarke RB, Brennan K. Aberrant activation of notch signaling in human breast cancer. Cancer Res 2006, 66(3):1517-1525. 10.1158/0008-5472.CAN-05-3054, 16452208.